TrialNature cancer2024

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.

Christina L Roland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.